{
  "symbol": "EDIT",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "CRISPR technology", "small-cap stock", "clinical stage developments"],
    "riskScore": 8,
    "reason": "Editas Medicine operates in the biotechnology sector with a focus on CRISPR technology, making it prone to speculative interest. Its small market cap and clinical stage developments further increase its susceptibility to social media-driven volatility."
  }
}